Related Experiment Video
Updated: Jul 8, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
Published on: January 26, 2019
A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella
1Department of Pediatrics, Universitair Ziekenhuis Antwerpen, Antwerp Belgium. jose.ramet@zna.be
Insights
Varicella (chickenpox) can cause severe complications and death, even in healthy children. Vaccination with the measles, mumps, rubella, and varicella (MMRV) vaccine significantly reduces disease impact and improves health outcomes.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Varicella, commonly known as chickenpox, is often perceived as a mild childhood illness.
- However, varicella can lead to severe complications and mortality, even in healthy individuals.
Purpose of the Study:
- To highlight the serious potential complications and mortality associated with varicella.
- To emphasize the benefits of the quadrivalent measles, mumps, rubella, and varicella (MMRV) vaccine in preventing varicella.
Main Methods:
- This abstract synthesizes findings from worldwide studies on varicella epidemiology and outcomes.
- It reviews the impact of existing vaccination programs utilizing the MMRV vaccine.
Main Results:
- Varicella is associated with significant morbidity, mortality, and healthcare resource utilization globally.
- Routine vaccination programs using the MMRV vaccine have demonstrated substantial reductions in varicella-related illness and death.
Conclusions:
- The measles, mumps, rubella, and varicella (MMRV) vaccine offers comprehensive protection against four common childhood diseases.
- Universal vaccination programs employing the MMRV vaccine are recommended to mitigate the medical and economic burden of varicella.
Background:
Varicella is often considered to be a benign disease of childhood. In fact, varicella is associated with serious complications and mortality even among healthy individuals.
Discussion:
Although the course of varicella can be uncomplicated, it can also be associated with serious complications such as pneumonia, fluid and electrolyte disturbances, skin and soft tissue infections and central nervous system disturbances. Worldwide studies have confirmed the high frequency of disease as well as the resultant morbidity, mortality and medical resource use. A quadrivalent vaccine is now available in certain countries to protect against measles, mumps, rubella and varicella (MMRV). Countries that have initiated routine vaccination pro- grams have reported substantial reductions in morbidity and mortality as well as improved health outcomes. The MMRV vaccine facilitates coverage against all four diseases, and would be expected to improve compliance as well as coverage of varicella.
Conclusions:
Universal vaccination programs with MMRV should be considered as a way to reduce the medical and economic impact of varicella. The MMRV vaccine provides a means to achieve universal coverage.
Related Concept Videos
Respiratory Syncytial Virus Disease
Vaccinations
Vaccines
Chickenpox
Poliomyelitis
Diphtheria

